# A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)

> **NCT07633301** · PHASE2 · RECRUITING · sponsor: **Takeda** · enrollment: 92 (estimated)

## Conditions studied

- Narcolepsy Type 1

## Interventions

- **DRUG:** TAK-360
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07633301
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-04
- **Primary completion:** 2027-11-28
- **Final completion:** 2027-11-28
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2026-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07633301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07633301, "A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07633301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*